We need to find our way back – to school, to work, to our friends, and to our families – but we need to do it safely. That is why we are advocating for wide-scale, preventative testing. Join us in helping to find #OurWayBack. Find out more here: initiative-wir-testen.de

CENTOGENE’s testing solution at Frankfurt Airport can serve as a blueprint for airports across the world – allowing for a safe reopening of air travel and bringing our society and economy one step closer to a new normal. Together, let’s find our way back.

It was a pleasure speaking with @sebastianbalzter about how we can overcome the Coronavirus - as long as we work together towards this goal. Let’s find #OurWayBack.

Before the outbreak of COVID-19, I would travel frequently – for conferences, meetings and humanitarian testing trips. With the opening of a walk-in testing facility at Frankfurt Airport, we can start reintroducing international travel in a safe, secure way.

Following guidelines from the World Health Organization (WHO), CENTOGENE’s diagnostic method for #COVID19 is extensively validated with 96.8% sensitivity and >99.9% specificity. While the science behind the test is quite complex, collecting a sample is easier than brushing your teeth.

Germany needs to act quickly and collectively for the health of our communities and the economy. This is exactly what Initiative - Wir testen stands for. Together, we are stronger.

This authorization is another milestone in our fight against a further #COVID19 outbreak & in support of a return to a #NewNormal. #CENTOGENE #Coronavirus #Testing #FDA #Diagnostics

Approximately 1% of individuals over 60 years old are affected by #ParkinsonsDisease. The ROPAD & LIPAD study aims to characterize the genetics of #PD to establish a better understanding of the disease progression, diagnosis, and treatment.

The symptoms of #RubinsteinTaybiSyndrome range from mild to severe, which means that diagnosis is often delayed until adolescence. Early diagnosis is key, allowing for early intervention and individual treatment programs that can impact their quality of life. #WorldRTSDay

Our team at CENTOGENE has been working around the clock to find innovative solutions amid the #COVID19 Pandemic. Combining our unsurpassed diagnostic knowledge, medical expertise, and passion, we have created the CentoTruck - an end-to-end testing solution.

CENTOGENE Clinical Scientist Salem Alawbathani presented research confirming USP53 as a causal gene for intrahepatic cholestasis. Using our in-house variant data repository, they found five additional patients from unrelated families. Amazing work! #ESHG2020

Since the outbreak of the COVID-19 Pandemic, our team at CENTOGENE has been diligently following the latest scientific publications to remain up to date on coronavirus research and best practices. Visit our Scientific Stories page to learn more: link.centogene.com/31NHZwp

By mid-March, most primary and secondary schools across the U.S. were forced to close in response to the coronavirus outbreak. This robbed students of something we consider essential to personal development and growth: an education. Let's get them back on track.

The CentoTruck is the first-of-its-kind mobile testing solution for COVID-19 PCR, and our team has been working around the clock to ensure its success. Remember – we must test, test, test!

Physicians are often faced with complex cases that progress quickly or cause life-hindering symptoms – making establishing a quick and precise diagnosis easier said than done. CentoGenome®, our Whole Genome Sequencing solution, can provide hope when it’s needed most.

CENTOGENE monitored a group of #Gaucher Disease patients for over 3 years – allowing us to track treatment efficiency with high sensitivity & specificity. We remain committed to our patients & continue to harness the power of biomarkers in the fight against rare disease.

CENTOGENE responded rapidly to #COVID19, establishing a holistic platform for preventative testing. In order to support a return to the ‘New Normal,’ we are suggesting an application of similar approaches on a much wider scale.

Rare Diseases, such as #Fabry, have varying features, thus requiring targeted treatments. We must always keep this at the forefront when treating patients and must continue carrying out research to support the approaches we take as a medical community!

The future of international travel lies in widespread, preventative testing – keeping passengers safe and allowing them to avoid restrictions at their destination. Only by working together, we will achieve the #NewNormal.

At CENTOGENE, we recognize the value that training has in guiding young people on their path of professional development. With our extensive apprenticeship program, we empower them to take their future into their own hands. Congratulations for their tremendous efforts!